[SLRX] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[SLRX] Salarius Pharmaceuticals, Inc.
Announcement Date
14-May-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -10.67%
YoY- 6.55%
Quarter Report
SLRX's Result
SLRX's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 1,479 1,378 1,243 1,133 1,039 875 165 328.65%
PBT -1,768 -1,717 -1,784 -2,084 -1,882 -2,630 -1,385 17.58%
Tax 10 -42 62 -286 1 -2 0 -
NP -1,768 -1,717 -1,784 -2,084 -1,883 -2,628 -1,385 17.58%
Tax Rate - - - - - - - -
Total Cost 3,246 3,095 3,028 3,217 2,922 3,503 1,549 63.38%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -119.52 -124.55 -143.51 -183.95 -181.27 -300.33 -840.76 -72.60%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -2.84 -2.39 -3.20 -5.46 -14.40 -18.22 -11.48 -60.42%
EPS Diluted -2.84 -2.39 -3.20 -5.46 -14.40 -18.22 -11.48 -60.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.